Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) have earned a consensus rating of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat reports. Thirteen equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month […]
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Given Average Recommendation of "Hold" by Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) Receives Average Recommendation of "Hold" from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Leerink Partnrs downgraded shares of Fusion Pharmaceuticals (NASDAQ:FUSN – Free Report) from an outperform rating to a market perform rating in a research note released on Tuesday, Zacks.com reports. Leerink Partnrs also issued estimates for Fusion Pharmaceuticals’ Q1 2024 earnings at ($0.33) EPS, FY2024 earnings at ($1.40) EPS and FY2025 earnings at ($1.42) EPS. Other […]
Fusion Pharmaceuticals (NASDAQ:FUSN) Downgraded to Hold at Brookline Capital Management theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.